N/A Completed N=40 Supportive Care

Glycemic Responses to Majia Pomelos in Type 2 Diabetic Patients

Diabetes

Source: ClinicalTrials.gov NCT02006836 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2014

Primary outcomePrimary: Glycemic Index — 76.79; 86.92 percentage of AUC from GI100 — p=0.005

Summary

Food intake has a great influence on blood glucose of patients with diabetes. This study was designed to determine the glycemic index (GI) of a particular pomelo named Majia pomelo and its effects on postprandial glucose (PPG) excursions in both healthy subjects and patients with type 2 diabetes (T2DM).

Outcome Measures

Outcome	Result	p-value
PRIMARY Glycemic Index	76.79; 86.92	0.005 sig
PRIMARY ∆g of Breakfast With/Without Pomelo	2.93; 3.61	>0.05
PRIMARY ∆g of Lunch With/Without Pomelo	1.39; 2.87	>0.05
PRIMARY ∆g of Dinner With/Without Pomelo	0.34; 1.41	>0.05
PRIMARY AUCs With/Without Pomelo	164.04; 163.07	>0.05

Eligibility Criteria

Inclusion Criteria

In the diabetic and diabetic 2 groups, it required that their diabetes was controlled (HbA1c ≤ 8%) on diet with or without metformin.

Exclusion Criteria

Morbid obesity (BMI > 40 kg/m2)
Pre diabetes
Pregnancy
Presence of gastroenterological disorders
Alimentary tract surgery
A history of gastroenteritis in the prior six months
Any alcohol intake
Smoking
Taking any medications (except metformin)
Poorly controlled diabetes (HbA1c > 8%)
Presence of chronic diseases (such as bronchial asthma or rheumatoid arthritis) or acute illness (such as upper respiratory tract or urinary tract infection)

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02006836). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.